TABLE 1 WORLD IV IBUPROFEN MARKET, MODERATE SCENARIO, BY COUNTRY, 2022 2027 ($MILLION)
TABLE 2 WORLD IV IBUPROFEN MARKET, RAPID GROWTH SCENARIO, BY COUNTRY, 2022 2027 ($MILLION)
TABLE 3 WORLD IV IBUPROFEN MARKET, DIMINISHING GROWTH SCENARIO, BY COUNTRY, 2022 2027 ($MILLION)
TABLE 4 CLINICAL TRIALS - ANALGESICS
TABLE 5 GLOBAL INCIDENCES OF DISEASES
TABLE 6 WORLD IV IBUPROFEN MARKET BY AGE GROUP, 2015-2022 ($MILLION)
TABLE 7 WORLD PEDIATRIC IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 8 WORLD ADULT IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 9 WORLD PAIN IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 10 WORLD FEVER IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 11 WORLD IV IBUPROFEN MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 12 UNITED STATES: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 13 CANADA: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 14 AUSTRALIA: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 15 SOUTH KOREA: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 16 COMPANY SNAPSHOT OF CUMBERLAND PHARMACEUTICALS
TABLE 17 CUMBERLAND PHARMACEUTICALS OPERATING SEGMENTS
TABLE 18 COMPANY SNAPSHOT OF ALVEDA PHARMACEUTICALS, INC.
TABLE 19 ALVEDA PHARMACEUTICALS, INC. OPERATING SEGMENTS
TABLE 20 COMPANY SNAPSHOT OF CSL LIMITED
TABLE 21 CSL LIMITED OPERATING SEGMENTS
TABLE 22 COMPANY SNAPSHOT OF SANDOR MEDICAIDS PVT LTD.
TABLE 23 SANDOR MEDICAIDS PVT LTD. OPERATING SEGMENTS
TABLE 24 COMPANY SNAPSHOT OF PT. SOHO INDUSTRI PHARMASI
TABLE 25 PT. SOHO INDUSTRI PHARMASI OPERATING SEGMENTS
TABLE 26 COMPANY SNAPSHOT OF GERMINMED
TABLE 27 GERMINMED OPERATING SEGMENTS
TABLE 28 COMPANY SNAPSHOT OF GRIFOLS S.A.
TABLE 29 GRIFOLS S.A. OPERATING SEGMENTS
TABLE 30 COMPANY SNAPSHOT OF HARBIN GLORIA PHARMACEUTICALS CO., LTD.
TABLE 31 COMPANY SNAPSHOT OF AL NABEEL INTERNATIONAL LTD.
TABLE 32 AL NABEEL INTERNATIONAL LTD. OPERATING SEGMENTS
TABLE 33 COMPANY SNAPSHOT OF LABORATORIOS VALMORCA
TABLE 34 LABORATORIOS VALMORCA OPERATING SEGMENTS

LIST OF FIGURE

FIG. 1 TOP IMPACTING FACTORS, MODERATE SCENARIO (2022-2027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)
FIG. 4 TOP INVESTMENT POCKETS OF IV IBUPROFEN MARKET BY COUNTRY, 2015-2022
FIG. 5 TOP WINNING STRATEGIES
FIG. 6 IV IBUPROFEN MARKET SHARE ANALYSIS, 2014
FIG. 7 TOP FACTORS IMPACTING WORLD IV IBUPROFEN MARKET, 2015-2022
FIG. 8 REVENUE GENERATED BY CUMBERLAND PHARMACEUTICALS (2012-2014)
FIG. 9 CUMBERLAND PHARMACEUTICALS, %REVENUE, BY PRODUCT, (2014)
FIG. 10 SWOT ANALYSIS OF CUMBERLAND PHARMACEUTICALS
FIG. 11 REVENUE GENERATED BY CSL LIMITED (2013-2015)
FIG. 12 CSL LIMITED, %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 13 CSL LIMITED, % REVENUE, BY GEOGRAPHY (2014)
FIG. 14 SWOT ANALYSIS OF CSL LIMITED
FIG. 15 REVENUE GENERATED BY GRIFOLS S.A. (2012-2014)
FIG. 16 GRIFOLS S.A., %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 17 GRIFOLS S.A., % REVENUE, BY GEOGRAPHY (2014)
FIG. 18 SWOT ANALYSIS OF GRIFOLS S.A.